CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $343,000 | -38.6% | 5,468 | -25.9% | 0.02% | -47.1% |
| Q4 2021 | $559,000 | -39.5% | 7,380 | -10.6% | 0.03% | -34.6% |
| Q3 2021 | $924,000 | +4.6% | 8,254 | +43.1% | 0.05% | -18.8% |
| Q4 2020 | $883,000 | -50.8% | 5,770 | -73.1% | 0.06% | +10.3% |
| Q3 2020 | $1,796,000 | -53.6% | 21,472 | -59.2% | 0.06% | -42.0% |
| Q2 2020 | $3,870,000 | +9.9% | 52,662 | -36.5% | 0.10% | +7.5% |
| Q1 2020 | $3,520,000 | +10.1% | 82,992 | +58.0% | 0.09% | +106.7% |
| Q4 2019 | $3,198,000 | – | 52,515 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |